Patents by Inventor Ralf Reiner Schumann

Ralf Reiner Schumann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090197851
    Abstract: A method of treating, preventing or ameliorating chronic heart failure or acute heart failure in a patient the method comprising administering to the patient an effective amount of: a compound that is able to bind to an endotoxin (lipopolysaccharide; LPS) molecule, for example LPS binding protein, BPI, lipoproteins, bile acids or an antibody capable of binding LPS, a compound that is able to bind to an endotoxin (lipopolysaccharide; LPS) molecule or bacterium in the gut, for example charcoal, a bile acid or Fuller's earth, an antibacterial agent that is substantially active in the gut, an agent that is able to inhibit the response by a cell to endotoxin (lipopolysaccharide; LPS), an agent that may form a barrier or that otherwise impedes translocation of bacteria or endotoxin (LPS) from the gut into the patient's circulation.
    Type: Application
    Filed: August 6, 2008
    Publication date: August 6, 2009
    Applicant: MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN
    Inventors: Stefan Anker, Andrew Coats, Hans-Dieter Volk, Mathias Rauchhaus, Ralf Reiner Schumann
  • Patent number: 6949512
    Abstract: A therapeutic agent for the treatment of septicemia, its preparation and use, with application in the pharmaceutical industry and medicine. This therapeutic agent contains essential element, the lipopolysaccharide binding protein (LBP). Also disclosed are LBP variants, mutants and hybrid proteins. Murine or rabbit LBP may also be used, besides human LBP.
    Type: Grant
    Filed: January 13, 2000
    Date of Patent: September 27, 2005
    Assignee: Max-Delbruck-Zentrum fur Molekulare Medizin
    Inventors: Ralf Reiner Schumann, Norbert Lamping